The Role of Genistein and its Derivatives in Ovarian Cancer: New Perspectives for Molecular Mechanisms and Clinical Applications
- PMID: 37921172
- DOI: 10.2174/0109298673251713231019091910
The Role of Genistein and its Derivatives in Ovarian Cancer: New Perspectives for Molecular Mechanisms and Clinical Applications
Abstract
Genistein (GEN) is a member of the polyphenol family, known chiefly for its effects on metabolic diseases and gynecological disorders. GEN has anti-cancer properties by inhibiting tumor proliferation, tumor metastasis, invasion, migration, and inducing apoptosis. Ovarian cancer (OC) is ranked 7th among the most common gynecological cancers. Despite its low incidence compared to other cancers, it is the first cause of death among gynecologic malignancies. Surgery and chemotherapy are the main options for treating this fatal cancer. Therefore, further investigations into GEN may aid in the discovery of novel therapeutics for preventing and/or treating OC. In this review, we aim to investigate the role of GEN in ovarian cancer. We investigate the anti-tumor effects of GEN on OC cell lines, including inducing apoptosis, suppressing tumor growth, and inhibiting metastasis. Also, we review the studies investigating GEN's roles as an adjuvant in therapeutic regimens with other chemotherapeutic agents (e.g., cisplatin, quercetin, and gemcitabine).
Keywords: Genistein; apoptosis; endometriosis; fatty acids.; gynecological cancers; ovarian cancer.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Unleashing the potential of Genistein and its derivatives as effective therapeutic agents for breast cancer treatment.Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3321-3343. doi: 10.1007/s00210-024-03579-6. Epub 2024 Nov 16. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39549063 Review.
-
An Updated Review Summarizing the Pharmaceutical Efficacy of Genistein and its Nanoformulations in Ovarian Carcinoma.Curr Pharm Des. 2025;31(2):107-115. doi: 10.2174/0113816128332618240823044548. Curr Pharm Des. 2025. PMID: 39354775 Review.
-
Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression.Biomed Pharmacother. 2021 Oct;142:111533. doi: 10.1016/j.biopha.2021.111533. Epub 2021 Jun 17. Biomed Pharmacother. 2021. PMID: 34148735
-
Genistein and its synthetic analogs as anticancer agents.Anticancer Agents Med Chem. 2012 Mar;12(3):271-81. doi: 10.2174/187152012800228788. Anticancer Agents Med Chem. 2012. PMID: 22043996 Review.
-
Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.Gynecol Oncol. 2007 Apr;105(1):23-30. doi: 10.1016/j.ygyno.2006.11.009. Epub 2007 Jan 17. Gynecol Oncol. 2007. PMID: 17234261
Cited by
-
Genistein inhibited endocytosis and fibrogenesis in keloid via CTGF signaling pathways.Genes Nutr. 2024 Oct 28;19(1):23. doi: 10.1186/s12263-024-00758-1. Genes Nutr. 2024. PMID: 39465374 Free PMC article.
-
Unleashing the potential of Genistein and its derivatives as effective therapeutic agents for breast cancer treatment.Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3321-3343. doi: 10.1007/s00210-024-03579-6. Epub 2024 Nov 16. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39549063 Review.
-
Phytochemical insights into flavonoids in cancer: Mechanisms, therapeutic potential, and the case of quercetin.Heliyon. 2025 Feb 13;11(4):e42682. doi: 10.1016/j.heliyon.2025.e42682. eCollection 2025 Feb 28. Heliyon. 2025. PMID: 40084006 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical